Recombinant Mouse Sentrin-specific protease 7 (Senp7), partial

Shipped with Ice Packs
In Stock

Description

Expression Patterns

Research indicates that Senp7 expression varies across different tissues and conditions:

StudyTissue TypeExpression LevelKey Findings
GlioblastomaReducedLower levels correlate with poor prognosis
Colon CancerElevatedAssociated with poor survival outcomes
Immune CellsVariableCritical for maintaining CD8+ T cell function

Functional Implications

Senp7's functional implications extend into various pathological contexts:

  • Cancer Progression: In glioblastoma, overexpression of Senp7 leads to decreased levels of proteins associated with tumor proliferation and metastasis, such as AKT and HIF-1α .

  • Immune Response Modulation: In the context of immune responses, Senp7 enhances the activation of cyclic GMP-AMP synthase (cGAS), which is crucial for triggering innate immunity pathways .

  1. Therapeutic Potential

Given its pivotal roles in cancer biology and immune regulation, targeting Senp7 presents a promising avenue for therapeutic intervention:

  • Cancer Therapy: Strategies aimed at increasing Senp7 expression or mimicking its activity could potentially inhibit tumor growth and metastasis in various cancers, particularly glioblastoma and colon cancer.

  • Immunotherapy Enhancement: By modulating Senp7 activity in immune cells, it may be possible to enhance the efficacy of immunotherapies against tumors.

Recombinant Mouse Sentrin-specific protease 7 is a multifaceted enzyme with significant implications for both cancer biology and immune function. Its ability to regulate SUMOylation processes positions it as a critical player in maintaining cellular homeostasis under stress conditions and offers potential therapeutic targets for enhancing cancer treatment strategies.

  1. Future Directions

Further research is warranted to elucidate the precise molecular mechanisms by which Senp7 operates within different cellular contexts. Investigating its interactions with other signaling pathways will provide deeper insights into its role in health and disease, paving the way for innovative therapeutic approaches.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can be used as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
Senp7; Kiaa1707; Susp2; Sentrin-specific protease 7; EC 3.4.22.-; SUMO-1-specific protease 2; Sentrin/SUMO-specific protease SENP7
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Mus musculus (Mouse)
Target Names
Senp7
Uniprot No.

Target Background

Function
A protease that deconjugates SUMO2 and SUMO3 from target proteins, but not SUMO1. It catalyzes the deconjugation of poly-SUMO2 and poly-SUMO3 chains. Its efficiency in processing full-length SUMO proteins to their mature forms is very low.
Gene References Into Functions
  1. SENP7 regulates zygotic DNA repair and spindle assembly, facilitating the maternal-to-zygotic transition. It influences histone H3 epigenetic modifications during oocyte and embryo development. PMID: 28315713
  2. Senp7 shows transient activation during early neuronal differentiation. PMID: 27039038
  3. Senp7 depletion redistributes HP1 alpha from pericentric heterochromatin without affecting H3K9me3 levels. PMID: 22388734
Database Links
Protein Families
Peptidase C48 family

Q&A

What is the biological role of Sentrin-specific protease 7 (Senp7) in cellular processes?

Sentrin-specific protease 7 (Senp7) is a member of the SUMO-specific protease family, which regulates the post-translational modification process known as SUMOylation. SUMOylation involves the attachment of small ubiquitin-like modifiers (SUMOs) to target proteins, influencing their stability, localization, and activity. Senp7 specifically acts as a SUMO-2/3-specific protease, catalyzing the de-SUMOylation of proteins modified by SUMO-2 and SUMO-3, but not SUMO-1 . This selective activity is critical for maintaining cellular homeostasis and regulating processes such as DNA repair, transcriptional regulation, and immune responses .

In the context of innate immunity, Senp7 has been shown to potentiate cGAS activation by relieving SUMO-mediated inhibition. This interaction underscores its role in modulating the cGAS-STING signaling pathway, which is essential for antiviral defense mechanisms . Additionally, structural analyses reveal unique features in the catalytic domain of Senp7 that distinguish it from other SENP family members, contributing to its substrate specificity and functional diversity .

How does Senp7 influence SUMOylation dynamics in vivo?

Senp7 regulates SUMOylation dynamics by selectively removing SUMO-2/3 modifications from target proteins. This activity is crucial for modulating protein-protein interactions and ensuring the proper functioning of cellular pathways. For instance, Senp7's de-SUMOylation activity has been implicated in the regulation of RanGAP1, a GTPase-activating protein involved in nucleocytoplasmic transport . By depolymerizing poly-SUMO-2 chains, Senp7 prevents excessive SUMOylation that could otherwise disrupt cellular functions.

Experimental studies using recombinant Senp7 have demonstrated its ability to depolymerize poly-SUMO-2 chains while exhibiting limited activity against poly-SUMO-1 chains. This paralogue-specific isopeptidase activity highlights its specialized role in maintaining the balance between SUMOylation and de-SUMOylation . Furthermore, knockdown experiments in mouse embryonic fibroblasts (MEFs) have shown that silencing Senp7 impairs the cGAS-STING axis, leading to reduced interferon production and increased susceptibility to viral infections .

What experimental models are commonly used to study Senp7 function?

To investigate the function of Senp7, researchers employ a variety of experimental models:

  • Cell-based assays: These include transfection studies using plasmids encoding wild-type or mutant forms of Senp7. Co-immunoprecipitation assays are commonly used to examine interactions between Senp7 and its substrates, such as cGAS or RanGAP1 .

  • Animal models: Knockdown or knockout mouse models are utilized to study the physiological roles of Senp7. For example, Senp7-knockdown mice have been used to explore its role in antiviral immunity and susceptibility to herpes simplex virus 1 (HSV-1) infection .

  • Structural studies: Crystallographic analyses provide insights into the unique features of the Senp7 catalytic domain, enabling researchers to understand its substrate specificity and enzymatic mechanisms .

  • Biochemical assays: Recombinant Senp7 proteins expressed in E. coli are used for in vitro assays to characterize its enzymatic activity against various SUMO isoforms .

These models collectively enable a comprehensive understanding of Senp7's biological functions and regulatory mechanisms.

How does the structural uniqueness of Senp7 contribute to its function?

The catalytic domain of Senp7 exhibits several structural features that differentiate it from other SENP family members. These include the absence of an N-terminal α-helix present in SENP1 and SENP2 structures, as well as unique loop insertions that contribute to its distinct substrate specificity . Structural comparisons reveal that while SENP1 and SENP2 share high sequence identity and structural similarity, Senp7 aligns poorly with these proteases due to these differences.

Crystallographic studies have further identified secondary structure elements unique to Senp7 that enhance its ability to interact with poly-SUMO-2/3 chains while excluding poly-SUMO-1 chains. These structural adaptations are critical for its role as a paralogue-specific isopeptidase . Understanding these features provides valuable insights into the design of selective inhibitors or modulators targeting Senp7 for therapeutic purposes.

What challenges arise when studying the enzymatic activity of recombinant Senp7?

Studying recombinant Senp7 poses several challenges:

  • Substrate specificity: The restricted substrate specificity of Senp7 necessitates careful selection of substrates for enzymatic assays. Researchers must ensure that the substrates used are appropriately modified with SUMO-2/3 rather than SUMO-1 .

  • Protein expression and purification: Recombinant expression systems, such as E. coli, may introduce post-translational modifications or folding issues that affect enzyme activity. Optimizing expression conditions and purification protocols is essential for obtaining functional recombinant proteins.

  • Assay sensitivity: Detecting de-SUMOylation activity requires sensitive assays capable of distinguishing between poly-SUMO-2/3 and mono-SUMOylated substrates. Techniques such as immunoprecipitation followed by Western blotting are commonly employed but may require optimization for specific substrates .

  • Physiological relevance: In vitro assays may not fully recapitulate the complex cellular environment where multiple factors influence Senp7 activity. Complementary studies using cell-based or animal models are necessary to validate findings.

Addressing these challenges involves a combination of biochemical, structural, and cellular approaches to ensure accurate characterization of Senp7's enzymatic properties.

How does Senp7 modulate immune signaling pathways?

Senp7 plays a pivotal role in modulating immune signaling pathways by regulating the SUMOylation status of key signaling molecules. One notable example is its interaction with cGAS, a cytosolic DNA sensor involved in antiviral immunity. SUMOylation suppresses cGAS activity by inhibiting its DNA-binding, oligomerization, and nucleotidyl-transferase functions. By catalyzing the de-SUMOylation of cGAS, Senp7 restores its activity and enhances downstream signaling through the STING pathway .

This regulatory mechanism has significant implications for immune responses against viral infections. Knockdown studies have shown that silencing Senp7 impairs interferon production and increases susceptibility to HSV-1 infection in mice . These findings highlight the importance of Senp7 in fine-tuning immune signaling pathways through dynamic modulation of protein post-translational modifications.

What methodologies are used to study protein-protein interactions involving Senp7?

Protein-protein interactions involving Senp7 can be studied using various methodologies:

  • Co-immunoprecipitation (co-IP): This technique allows researchers to identify physical interactions between Senp7 and its substrates or binding partners. For example, co-IP assays have demonstrated specific interactions between Senp7 and cGAS but not with other components of the STING pathway .

  • Yeast two-hybrid screening: This method can be used to identify novel interacting partners of Senp7 by screening libraries of potential binding proteins.

  • Surface plasmon resonance (SPR): SPR provides quantitative measurements of binding affinities between Senp7 and its substrates or inhibitors.

  • X-ray crystallography: Structural studies can reveal interaction interfaces between Senp7 and its substrates at atomic resolution .

  • Mutagenesis studies: Site-directed mutagenesis can be employed to identify critical residues involved in substrate recognition or enzymatic activity.

These methodologies enable detailed characterization of protein-protein interactions involving Senp7, shedding light on its functional roles in cellular processes.

How can researchers investigate the physiological roles of partial or truncated forms of recombinant mouse Senp7?

Investigating partial or truncated forms of recombinant mouse Senp7 requires a combination of experimental approaches:

These approaches provide insights into how partial or truncated forms influence the function and regulation of mouse Senp7.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.